NCEL
NewcelX Ltd.NASDAQHealthcare$2.14-5.10%ClosedMarket Cap: $963,000
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.30
P/S
0.00
EV/EBITDA
0.55
DCF Value
$10.09
FCF Yield
-500.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-101.0%
ROA
-49.9%
ROIC
-142.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $0.00 | -Infinity% | $-1.8M | $-2.2M | $-10.50 | — |
| Q4 2024 | $0.00 | Infinity% | $-2.3M | $55.0K | $-9.90 | — |
| FY 2024 | $0.00 | -Infinity% | $-4.4M | $-2.0M | $-26.30 | — |
| Q2 2024 | $0.00 | -Infinity% | $-2.1M | $-2.0M | $0.00 | — |
| Q4 2023 | $0.00 | -Infinity% | $-4.3M | $-4.6K | $-1.40 | — |
| FY 2023 | $0.00 | -Infinity% | $-11.8M | $-12.2M | $-3.20 | — |
| Q2 2023 | $0.00 | -Infinity% | $-7.5M | $-7.6M | $-2.00 | — |
| Q4 2022 | $0.00 | -Infinity% | $-6.8M | $-7.9M | $-2.90 | — |
| FY 2022 | $0.00 | -Infinity% | $-15.5M | $-16.5M | $-8.40 | — |
| Q2 2022 | $0.00 | -Infinity% | $-8.7M | $-8.6M | $-5.40 | — |
| Q4 2021 | $0.00 | -Infinity% | $-7.3M | $-7.3M | $-5.00 | — |
| FY 2021 | $0.00 | -Infinity% | $-11.9M | $-11.9M | $-8.10 | — |